Manning & Napier Advisors LLC Purchases Shares of 3,554 Humana Inc. $HUM

Manning & Napier Advisors LLC bought a new position in shares of Humana Inc. (NYSE:HUM) during the 2nd quarter, Holdings Channel.com reports. The firm bought 3,554 shares of the insurance provider’s stock, valued at approximately $1,412,000.

A number of other hedge funds have also recently added to or reduced their stakes in the business. BlackRock Inc. acquired a new position in Humana during the second quarter valued at approximately $4,138,160,000. Pzena Investment Management LLC acquired a new position in shares of Humana during the 2nd quarter valued at $1,749,014,000. Capital International Investors boosted its position in Humana by 113.9% during the 4th quarter. Capital International Investors now owns 5,818,008 shares of the insurance provider’s stock worth $1,490,239,000 after purchasing an additional 3,097,571 shares during the period. Norges Bank acquired a new stake in Humana in the 4th quarter valued at $456,632,000. Finally, Wellington Management Group LLP raised its position in Humana by 4,481.7% in the fourth quarter. Wellington Management Group LLP now owns 1,196,502 shares of the insurance provider’s stock valued at $306,460,000 after purchasing an additional 1,170,387 shares during the period. 92.38% of the stock is owned by institutional investors and hedge funds.

Humana Stock Performance

Humana stock opened at $388.92 on Wednesday. The company has a market cap of $46.70 billion, a PE ratio of 36.79, a P/E/G ratio of 2.20 and a beta of 0.72. The company has a fifty day moving average price of $383.88 and a two-hundred day moving average price of $285.00. The company has a debt-to-equity ratio of 0.62, a current ratio of 1.74 and a quick ratio of 1.74. Humana Inc. has a 12 month low of $163.11 and a 12 month high of $428.88.

Humana (NYSE:HUM) last issued its earnings results on Wednesday, July 29th. The insurance provider reported $7.61 EPS for the quarter, beating analysts’ consensus estimates of $7.27 by $0.34. The company had revenue of $40.89 billion during the quarter, compared to the consensus estimate of $40.58 billion. Humana had a return on equity of 11.20% and a net margin of 0.88%.Humana’s quarterly revenue was up 26.2% compared to the same quarter last year. During the same period in the previous year, the firm posted $6.27 earnings per share. Research analysts expect that Humana Inc. will post 9.12 earnings per share for the current year.

Wall Street Analysts Forecast Growth

HUM has been the topic of several analyst reports. Wells Fargo & Company upgraded Humana from an “equal weight” rating to an “overweight” rating and raised their target price for the company from $227.00 to $502.00 in a report on Monday, July 13th. Oppenheimer reaffirmed an “outperform” rating and issued a $405.00 price objective on shares of Humana in a research report on Thursday, July 30th. Lake Street Capital initiated coverage on shares of Humana in a research note on Thursday, July 30th. They set a “buy” rating on the stock. Robert W. Baird set a $390.00 target price on shares of Humana in a research report on Thursday, July 30th. Finally, Guggenheim upped their target price on shares of Humana from $269.00 to $471.00 and gave the company a “buy” rating in a research note on Thursday, July 30th. Fourteen research analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $403.91.

Humana Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.